IRIS
ARTESE, Anna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.146
AS - Asia 1.116
EU - Europa 1.078
SA - Sud America 107
AF - Africa 18
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
Totale 4.474
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.060
SG - Singapore 581
IT - Italia 472
CN - Cina 374
DE - Germania 181
GB - Regno Unito 111
FI - Finlandia 92
BR - Brasile 88
SE - Svezia 82
CA - Canada 70
IN - India 54
UA - Ucraina 47
VN - Vietnam 24
HK - Hong Kong 22
EE - Estonia 20
ES - Italia 17
JP - Giappone 13
NL - Olanda 11
FR - Francia 10
MX - Messico 10
CZ - Repubblica Ceca 8
IQ - Iraq 8
AR - Argentina 7
TR - Turchia 7
BD - Bangladesh 5
EU - Europa 5
ZA - Sudafrica 5
IR - Iran 4
PL - Polonia 4
DZ - Algeria 3
LT - Lituania 3
TW - Taiwan 3
UY - Uruguay 3
AF - Afghanistan, Repubblica islamica di 2
AL - Albania 2
AT - Austria 2
CL - Cile 2
CO - Colombia 2
DK - Danimarca 2
EG - Egitto 2
IL - Israele 2
KE - Kenya 2
KZ - Kazakistan 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PE - Perù 2
PH - Filippine 2
PT - Portogallo 2
RO - Romania 2
SA - Arabia Saudita 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AU - Australia 1
BG - Bulgaria 1
CH - Svizzera 1
CU - Cuba 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
ET - Etiopia 1
GP - Guadalupe 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
ID - Indonesia 1
IE - Irlanda 1
JO - Giordania 1
KG - Kirghizistan 1
LB - Libano 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
MU - Mauritius 1
NG - Nigeria 1
NP - Nepal 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PW - Palau 1
PY - Paraguay 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
Totale 4.474
Salva come PNG Salva come JPEG
Città #
Chandler 336
Singapore 218
Dallas 185
Santa Clara 159
Munich 153
Hefei 145
Ashburn 142
Milan 130
Lawrence 124
Princeton 124
London 75
Wilmington 70
Chicago 58
Helsinki 55
Ottawa 54
Des Moines 46
Catanzaro 40
Los Angeles 29
Turku 27
Shanghai 26
Hong Kong 21
Washington 19
Boardman 16
Brooklyn 16
Guangzhou 15
Pune 15
San Francisco 15
New York 13
Rome 13
Beijing 12
Shenzhen 11
Redmond 10
São Paulo 10
Tokyo 10
Ho Chi Minh City 9
Norwalk 9
Casoria 8
Chennai 8
Olomouc 8
Phoenix 8
San Nicola Manfredi 8
Cagliari 7
Hanoi 7
Naples 7
Boston 6
Crotone 6
Hanover 6
Jyväskylä 6
Messina 6
Seattle 6
Weihai 6
Catania 5
Charlotte 5
Columbus 5
Denver 5
Luni 5
Montreal 5
Palermo 5
Redwood City 5
San Mateo 5
The Dalles 5
Toronto 5
Wuhan 5
Anagni 4
Atlanta 4
Aversa 4
Brasília 4
Council Bluffs 4
Dongyang 4
Heidesheim 4
Jiaxing 4
Johannesburg 4
Santander 4
Siena 4
Stockholm 4
Treviso 4
Vallefiorita 4
Afragola 3
Amsterdam 3
Avola 3
Bonn 3
Castrovillari 3
Cosenza 3
Curitiba 3
Erbil 3
Ferrara 3
Fuzhou 3
Giulianova 3
Jinan 3
Lamezia Terme 3
Las Vegas 3
Latina 3
Montevideo 3
Mumbai 3
Orem 3
Padova 3
Pavia 3
Poplar 3
Rui'an 3
San Cristóbal de La Laguna 3
Totale 2.698
Salva come PNG Salva come JPEG
Nome #
(3Z)-3-(2-[4-(aryl)-1,3-thiazol-2-yl]hydrazin-1-ylidene)-2,3-dihydro-1H-indol-2-one derivatives as dual inhibitors of HIV-1 reverse transcriptase 184
A Candidate multi-targeting approach to block the CD98hc oncoprotein 78
GBPM: applicazione al docking molecolare 74
A drug repurposing screening reveals a novel epigenetic activity of hydroxychloroquine. 72
Mediterranean products as promising source of multi-target agents in the treatment of metabolic syndrome 66
Isolation and Functional Characterization of Peptide Agonists of PTPRJ, a Tyrosine Phosphatase Receptor Endowed with Tumor Suppressor Activity. 63
A Computational pathway toward the rational design of azinomycin analogues 62
Ligand binding to telomeric G-quadruplex DNA investigated by funnel-metadynamics simulations 59
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses 59
Back Cover: Hit Identification of a Novel Dual Binder for h-telo/c-myc G-Quadruplex by a Combination of Pharmacophore Structure-Based Virtual Screening and Docking Refinement (ChemMedChem 16/2016) 58
Chemioterapici antifungini 58
Chromenone derivatives as a versatile scaffold with dual mode of inhibition of HIV-1 reverse transcriptase-associated Ribonuclease H function and integrase activity 55
Abstract B122: The CD98hc oncoprotein as a target of new anticancer therapy 54
Identification and Characterization of New DNA G-Quadruplex Binders Selected by a Combination of Ligand and Structure-Based Virtual Screening Approaches 53
Molecular recognition of a carboxy pyridostatin towards G-quadruplex structures: why does it prefer RNA? 51
A Comparative Docking Strategy to Identify Polyphenolic Derivatives as Promising Antineoplastic Binders of G-quadruplex DNA c-myc and bcl-2 Sequences 51
The Mediterranean Diet as source of bioactive compounds with multi-targeting anti-cancer profile 51
Characterization and Structural Analysis of Novel Mutations in HIV-1 Reverse Transcriptase Involved in the Regulation of Resistance to Non-Nucleoside Inhibitors 50
In silico identification and biological evaluation of novel selective serum/glucocorticoid-inducible kinase 1 inhibitors based on the pyrazolo-pyrimidine scaffold 47
Discovery of PTPRJ Agonist Peptides That Effectively Inhibit in Vitro Cancer Cell Proliferation and Tube Formation. 47
Molecular recognition studies of dasabuvir, tegobuvir, and setrobuvir against natural Hepatitis C Virus NS5B polymerase variants. 47
Aryl ethynyl anthraquinones: a useful platform for targeting telomeric G-quadruplex structures 46
Characterization of the role of two additional HIV-1 reverse transcriptase mutations in the regulation of NNRTI resistance 45
CoMFA studies of non covalent monoamine oxidase inhibitors 45
Novel natural non-nucleoside inhibitors of HIV-1 reverse transcriptase identified by shape- and structure-based virtual screening techniques 45
SI113, a Specific Inhibitor of the Sgk1 Kinase Activity that Counteracts Cancer Cell Proliferation 45
Comparison of molecular dynamics simulations carried out on wild type and mutants of HIV-1 reverse transcriptase 45
Identification and Structural Characterization of Novel Genetic Elements in HIV-1 - V3 Loop Regulating Co-Receptor Usage 44
Computer-based techniques for lead identification and optimization II: Advanced search methods 44
In Silico Identification of Piperidinyl-amine Derivatives as Novel Dual Binders of Oncogene c-myc/c-Kit G-quadruplexes 43
Hit Identification of a Novel Dual Binder for h-telo/c-myc G-Quadruplex by a Combination of Pharmacophore Structure-Based Virtual Screening and Docking Refinement 43
Characterization and structural analysis of HIV-1 integrase conservation 43
A computer-assisted discovery of novel potential anti-obesity compounds as selective carbonic anhydrase VA inhibitors 43
Comparison of Computational Methods in Docking Experiments of G-Quadruplex Binders 42
Identification of G-quadruplex DNA/RNA binders: Structure-based virtual screening and biophysical characterization 42
Chromene Derivatives as Selective TERRA G-Quadruplex RNA Binders with Antiproliferative Properties 41
In silico identification and biological evaluation of antioxidant food components endowed with IX and XII hCA inhibition 41
From Homology Modeling to the Hit Identification and Drug Repurposing: A Structure-Based Approach in the Discovery of Novel Potential Anti-Obesity Compounds 40
Hybrid ligand-alkylating agents targeting telomeric G-quadruplex structures 40
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 39
In Silico-Guided Rational Drug Design and Synthesis of Novel 4-(Thiophen-2-yl)butanamides as Potent and Selective TRPV1 Agonists 39
Computational analysis of human immunodeficiency virus (HIV) type-1 reverse transcriptase crystallographic models based on significant conserved residues found in highly active antiretroviral therapy (HAART)-treated patients 39
Folding intermediate states of the parallel human telomeric G-quadruplex DNA explored using Well-Tempered Metadynamics 39
Natural products extracted from fungal species as new potential anti-cancer drugs: A structure-based drug repurposing approach targeting HDAC7 38
Targeting multiple G-quadruplex–forming DNA sequences: Design, biophysical and biological evaluations of indolo-naphthyridine scaffold derivatives 37
Computer-based techniques for lead identification and optimization i: Basics 36
Multi-targeting bioactive compounds extracted from essential oils as kinase inhibitors 36
Design, Synthesis, and Evaluation of New Tripeptides as COX-2 Inhibitors 35
Dinamica molecolare di complessi della proteasi di HIV-1: influenza di mutazioni associate a resistenza sulla ricognizione molecolare 35
Computational analysis of HIV-1 reverse transcriptase complexes 35
Composti per il G-quadruplex a struttura naftilimmidica 35
Discovery of PTPRJ agonist peptides that effectively inhibit in vitro cancer cell proliferation and tube formation 34
Indagine statistica sulla diffusione nell’Industria farmaceutica italiana di tecnologie computazionali avanzate orientate alla progettazione di nuovi farmaci 34
Incomplete APOBEC3G/F Neutralization by HIV-1 Vif Mutants Facilitates the Genetic Evolution from CCR5 to CXCR4 Usage 33
Hepatitis C Virus Genetic Variability and the Presence of NS5B Resistance-Associated Mutations as Natural Polymorphisms in Selected Genotypes Could Affect the Response to NS5B Inhibitors 33
Metodi computazionali e nutraceutica 33
Identification of new G-quadruplex binders by combined virtual screening approaches. 33
Progettazione razionale di agenti bisalchilanti del DNA analoghi delle azinomicine 33
Targeting SARS-CoV-2 Main Protease: A Successful Story Guided by an In Silico Drug Repurposing Approach 32
Conformational studies and solvent-accessible surface area analysis of known selective DNA G-Quadruplex binders 32
Molecular and structural aspects of clinically relevant mutations related to the approved non-nucleoside inhibitors of HIV-1 reverse transcriptase 31
Conformational analysis of bioactive conformations in the drug discovery process 31
Computational study on DNA G-quadruplex binding compounds 31
Identification of New Natural DNA G-Quadruplex Binders Selected by a Structure-Based Virtual Screening Approach 31
Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune control 31
Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile 30
GBPM analysis of HIV-1 reverse transcriptase–DNA crystallographic complexes focused on the enzyme conserved regions of HAART-treated patients 30
High-throughput lipophilicity screening of opioid-like analgesics: validation of computational methods by means of RP-HPLC analysis 29
Conformation and stability of intramolecular telomeric g-quadruplexes: sequence effects in the loops 29
Design and Synthesis of a (N-Alkylaminoalkyl-Substituted) Arylalkenylamide Drug Discovery Library 29
Computational approaches for discovery and optimization of G-quadruplex binders 28
null 28
An overview on olfaction in the biological, analytical, computational, and machine learning fields 27
Molecular and Structural Aspects of Clinically Relevant Mutations of SARS-CoV-2 RNA-Dependent RNA Polymerase in Remdesivir-Treated Patients 26
Hit identification of novel DNA-quadruplex ligands 26
Kaempferol as Selective Human MAO-A Inhibitor: Analytical Detection in Calabrian Red Wines, Biological and Molecular Modeling Studies 26
Molecular interaction fields in drug discovery: recent advances and future perspectives 26
New Resistance Mutations to Nucleoside Reverse Transcriptase Inhibitors at Codon 184 of HIV-1 Reverse Transcriptase (M184L and M184T). 26
Docking e virtual screening su composti naturali: esempi su quercitina e cucurbitacina 25
Docking studies of Lopinavir, Atazanavir and Darunavir binding modes to HIV-1 protease mutants 25
STATISTICAL ANALISYS OF DRUG DESIGN COMPUTATIONAL TECNIQUES AMONG THE RESEARCH GROUPS IN ITALY 25
Pathway involving the N155H mutation in HIV-1 integrase leads to dolutegravir resistance 25
The polymorphisms of DNA g-quadruplex investigated by docking experiments with telomestatin enantiomers 25
SARS-CoV-2 Variants and Their Relevant Mutational Profiles: Update Summer 2021 24
Molecular Recognition Of Dna G-Quadruplex Ligands By Different Docking Methods 24
Rational drug design of DNA cross-linking agents 24
Computer-based techniques for lead identification and optimization I: Basics 23
Molecular dynamics and free energy studies on the wild-type and mutated HIV-1 protease complexed with four approved drugs: mechanism of binding and drug resistance 23
Docking comparativo per lo sviluppo di ligandi per il DNA G-Quadruplex 23
Structural Modeling of New Polymorphism Clusters of HCV Polymerase Isolated from Direct-Acting Antiviral Naïve Patients: Focus on Dasabuvir and Setrobuvir Binding Affinity 23
Hit Identification and Functional Validation of Novel Dual Inhibitors of HDAC8 and Tubulin Identified by Combining Docking and Molecular Dynamics Simulations 22
Design and Synthesis of New Transient Receptor Potential Vanilloid Type-1 (TRPV1) Channel Modulators: Identification, Molecular Modeling Analysis, and Pharmacological Characterization of the N-(4-Hydroxy-3-methoxybenzyl)-4-(thiophen-2-yl)butanamide, a Small Molecule Endowed with Agonist TRPV1 Activity and Protective Effects against Oxidative Stress 22
Indagine statistica sulla diffusione delle tecnologie computazionali avanzate per la progettazione dei nuovi farmaci 22
Rational drug design of DNA G-quadruplex binders using structure-based computational approaches. 22
Molecular docking, synthesis and biological evaluation of indomethacin analogs as novel cyclooxygenase inhibitors. 22
Studio computazionale su modelli PDB di HIV-1 21
Rational drug design of DNA G-quadruplex binders using in silico approaches 21
Effect of maraviroc on non-R5 tropic HIV-1: refined analysis of subjects from the phase IIb study A4001029 21
Correction: Curcio et al. The Histone Deacetylase Family: Structural Features and Application of Combined Computational Methods. Pharmaceuticals 2024, 17, 620 20
HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitors 20
Totale 3.873
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.355
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.355
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021155 0 0 20 20 27 20 23 4 16 13 8 4
2021/2022331 4 2 10 64 23 6 14 80 22 33 69 4
2022/20231.003 253 48 46 72 111 72 9 70 156 59 83 24
2023/2024513 72 57 46 31 33 152 12 45 4 21 16 24
2024/20251.709 204 143 65 59 117 199 92 66 221 119 155 269
2025/2026694 172 358 164 0 0 0 0 0 0 0 0 0
Totale 4.566